Deborah M. Autor - Net Worth and Insider Trading
Deborah M. Autor Insider Ownership Reports
Deborah M. Autor Trading Performance
Deborah M. Autor Ownership Network
Ownership Network List of Deborah M. Autor
Ownership Network Relation of Deborah M. Autor
Deborah M. Autor Owned Company Details
What does Pardes Biosciences Inc do?
Pardes Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel oral-antiviral therapeutics to improve the lives of patients suffering from life-threatening disease, starting with the lead product candidate, pomotrelvir (formerly known as PBI-0451), which is in clinical development and intended to treat COVID-19 in adult and pediatric patients. COVID-19 is caused by infection with the severe acute respiratory syndrome coronavirus (SARS-CoV-2). Pomotrelvir inhibits the main coronaviral cysteine protease, a viral protein essential for the replication of all known coronaviruses, including SARS-CoV-2.
Who are the key executives at Pardes Biosciences Inc?
Deborah M. Autor is the director of Pardes Biosciences Inc. Other key executives at Pardes Biosciences Inc include 10 percent owner Fs Development Holdings Ii, Llc , director & Chief Executive Officer Thomas G Wiggans , and director & 10 percent owner James B. Tananbaum .
Pardes Biosciences Inc (PRDS) Insider Trades Summary
Over the past 18 months, Deborah M. Autor made no insider transaction in Pardes Biosciences Inc (PRDS). Other recent insider transactions involving Pardes Biosciences Inc (PRDS) include a net purchase of 50,000 shares made by Thomas G Wiggans , a net purchase of 773,952 shares made by Foresite Capital Opportunity Fund V, L.p. , and a net purchase of 773,952 shares made by Foresite Capital Fund V, L.p. .
In summary, during the past 3 months, insiders sold 0 shares of Pardes Biosciences Inc (PRDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pardes Biosciences Inc (PRDS) were sold and 2,256,324 shares were bought by its insiders, resulting in a net purchase of 2,256,324 shares.
Pardes Biosciences Inc (PRDS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pardes Biosciences Inc Insider Transactions
Deborah M. Autor Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah M. Autor. You might contact Deborah M. Autor via mailing address: C/o Pardes Biosciences, Inc., 2173 Salk Ave., Suite 250, Pmb#052, Carlsbad Ca 92008.